InstalabHLA Typing for Celiac Disease
Should you take a HLA Typing for Celiac Disease test?
This test is most useful if any of these apply to you.
4 Biomarkers Included
- HLA-DQ2 (DQA1*05/DQB1*02)The main celiac risk molecule, carried by roughly 90 to 95 percent of people with the disease. Its presence is the single most important thing this panel looks for.Carrying DQ2, especially two copies, marks the highest genetic susceptibility to celiac disease.
- HLA-DQ8 (DQA1*03/DQB1*0302)The second permissive molecule, carried by many people with celiac disease who lack DQ2. Testing it alongside DQ2 is what lets the panel rule the disease out.DQ8 catches part of the celiac-prone minority that a DQ2-only test would miss.
- HLA-DQA1*One half of the risk molecules, the alpha chain. Reading these variants shows which risk molecules your body can actually build, including combinations formed across both chromosomes.The alpha-chain variants can reveal risk patterns that a simple DQ2 or DQ8 result misses.
- HLA-DQB1*The other half, the beta chain. The DQB1*02 variant carries the strongest celiac signal, and having two copies of it points to the steepest risk.A double dose of DQB1*02 confers the greatest genetic risk of celiac disease.
About HLA Typing for Celiac Disease
Most celiac disease tests look for damage that has already started: the antibodies your immune system makes against gluten, or injury to the lining of your small intestine. This panel looks further upstream, at whether your body is even genetically built to develop the disease at all. That answer is written in your DNA and never changes.
This makes the panel unusually good at one thing: ruling celiac disease out. If you do not carry the permissive genes, the disease is extraordinarily unlikely, whether you eat bread every day or gave up gluten years ago.
What This Panel Reveals
Your immune system relies on a family of genes called HLA (human leukocyte antigen) genes to tell your own tissue apart from outside threats. Nearly everyone who develops celiac disease carries one of two immune molecules, DQ2 or DQ8, that can grab onto fragments of gluten and show them to the immune system. Without one of these molecules, the gluten reaction that drives celiac disease cannot get started.
DQ2 is the dominant player. It is built from two gene pieces, DQA105 and DQB102, and it is found in roughly 90 to 95 percent of people with celiac disease. DQ8, built from DQA103 and DQB10302, accounts for many of the remaining cases, alongside a lower-risk cousin of DQ2 (called DQ2.2) that shares the DQB1*02 gene piece. Reading the full set of DQA1 and DQB1 variants at once is the whole point of the panel, because testing for just one molecule would quietly miss the others.
The panel does not stop at naming DQ2 and DQ8. By reading the underlying DQA1 and DQB1 gene variants directly, it shows how the risk pieces are arranged and how many copies you carry. Two copies of the DQB1*02 variant, sometimes called a double dose, carry the steepest risk, while a single copy or only part of the pair carries less.
How to Read Your Results Together
The value of this panel is in the pattern, not any single line. Here is how the common combinations translate.
| Your Result | What It Means |
|---|---|
| Neither DQ2 nor DQ8 present | Celiac disease is essentially ruled out for life. Look elsewhere for the cause of your symptoms. |
| DQ2 or DQ8 present | Celiac disease is genetically possible. Antibody blood tests are needed to see if it is active. |
| Two copies of DQ2, or a double dose of DQB1*02 | The highest genetic risk. Worth proactive antibody testing even without symptoms. |
| Only part of a risk pair, such as DQB102 without DQA105 | Low but not zero risk. A specialist can weigh this against your other results. |
To put the risk gradient in perspective, people carrying two copies of DQ2 have shown almost 97 times the odds of a positive celiac antibody test compared with people who carry non-permissive genes. A positive genetic result still is not a diagnosis, but it tells you how closely to pay attention.
What to Do with Your Results
If the panel is negative, celiac disease is very unlikely to be your problem, now or in the future. When both DQ2 and DQ8 are absent, the disease is correctly excluded more than 99 percent of the time, so you can generally stop repeat celiac screening and investigate other causes.
If the panel is positive, the next move is celiac antibody testing, ideally a tissue transglutaminase antibody (tTG) test with a total immunoglobulin A (IgA) level, done while you are still eating gluten. Abnormal antibodies warrant a gastroenterology referral and, in many cases, a small intestine biopsy. Because this genetic result is fixed for life, you never need to repeat the panel; only the antibody follow-up gets tracked over time.
When Results Can Be Misleading
A positive result is common and easily over-read. Between 30 and 40 percent of the general population carries DQ2 or DQ8, yet only about 3 percent of those people ever develop celiac disease, so a positive result signals possibility, not presence. Reading it as a diagnosis is the most frequent mistake.
Two other cautions matter. Basic testing that reports only DQ2 and DQ8 can miss risk pieces split across your two chromosomes, which is why reading the full DQA1 and DQB1 variants is worthwhile. And in rare cases, about 3 in 100 people with confirmed celiac disease lack both DQ2 and DQ8, though many still carry a partial DQ2 variant that reading the full DQB1*02 gene piece can pick up. A truly negative result paired with strong biopsy evidence should be reviewed by a specialist rather than taken as final.